BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31523116)

  • 1. DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts.
    Yonemura H; Futakuchi A; Inoue-Mochita M; Fujimoto T; Takahashi E; Tanihara H; Inoue T
    Mol Vis; 2019; 25():382-390. PubMed ID: 31523116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aza-2'-deoxycytidine induces human Tenon's capsule fibroblasts differentiation and fibrosis by up-regulating TGF-β type I receptor.
    Fu S; Sun L; Zhang X; Shi H; Xu K; Xiao Y; Ye W
    Exp Eye Res; 2017 Dec; 165():47-58. PubMed ID: 28893564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 epigenetically modifies Thy-1 expression in primary lung fibroblasts.
    Neveu WA; Mills ST; Staitieh BS; Sueblinvong V
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C616-26. PubMed ID: 26333597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts.
    Futakuchi A; Inoue T; Fujimoto T; Inoue-Mochita M; Kawai M; Tanihara H
    Exp Eye Res; 2016 Aug; 149():107-115. PubMed ID: 27394186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis.
    Seet LF; Toh LZ; Finger SN; Chu SW; Stefanovic B; Wong TT
    J Mol Med (Berl); 2016 Mar; 94(3):321-34. PubMed ID: 26507880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
    Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA).
    Futakuchi A; Inoue T; Fujimoto T; Kuroda U; Inoue-Mochita M; Takahashi E; Ohira S; Tanihara H
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2421-2429. PubMed ID: 28448670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CLC-2 Chloride Channel Modulates ECM Synthesis, Differentiation, and Migration of Human Conjunctival Fibroblasts via the PI3K/Akt Signaling Pathway.
    Sun L; Dong Y; Zhao J; Yin Y; Zheng Y
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the methylation enzyme inhibitors of 5-aza-2-deoxycytidine on the TGF-beta/smad signal transduction pathway in human keloid fibroblasts].
    Zou QP; Yang E; Zhang HS
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jul; 29(4):285-9. PubMed ID: 24228511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
    Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
    Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitasone and ROCK Inhibitors Modulate Fibrogenetic Changes in TGF-β2 Treated Human Conjunctival Fibroblasts (HconF) in Different Manners.
    Oouchi Y; Watanabe M; Ida Y; Ohguro H; Hikage F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
    Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
    Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
    Cho JW; Il KJ; Lee KS
    Int J Mol Med; 2013 May; 31(5):1148-52. PubMed ID: 23503720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
    Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-aza-2'-Deoxycytidine, a DNA methyltransferase inhibitor, facilitates the inorganic phosphorus-induced mineralization of vascular smooth muscle cells.
    Azechi T; Sato F; Sudo R; Wachi H
    J Atheroscler Thromb; 2014; 21(5):463-76. PubMed ID: 24441913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
    Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A
    Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
    Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.